Vosaroxin and Decitabine in Newly Diagnosed Older Patients with AML and High Risk MDS

At ASH 2015, Dr. Naval Daver from MD Anderson discussed his abstract titled "Phase I/II Study of Vosaroxin and Decitabine in Newly Diagnosed Older Patients (pts) with Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)."